{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:06:21Z","timestamp":1789761981777,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01 HS024412"],"award-info":[{"award-number":["R01 HS024412"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23 AR063770"],"award-info":[{"award-number":["K23 AR063770"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00296-017-3782-6","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T17:57:57Z","timestamp":1501091877000},"page":"1611-1618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-4626","authenticated-orcid":false,"given":"Milena A.","family":"Gianfrancesco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Schmajuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Haserodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Trupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara","family":"Izadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Shiboski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Adams Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinoos","family":"Yazdany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"key":"3782_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/acr.20133","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Marmor MF (2010) Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62:775\u2013784","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3782_CR2","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/art.1780400817","volume":"40","author":"GD Levy","year":"1997","unstructured":"Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T (1997) Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum 40:1482\u20131486","journal-title":"Arthritis Rheum"},{"key":"3782_CR3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0161-6420(03)00409-3","volume":"110","author":"I Mavrikakis","year":"2003","unstructured":"Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C et al (2003) The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 110:1321\u20131326","journal-title":"Ophthalmology"},{"key":"3782_CR4","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","volume":"132","author":"RB Melles","year":"2014","unstructured":"Melles RB, Marmor MF (2014) The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 132:1453\u20131460","journal-title":"JAMA Ophthalmol"},{"key":"3782_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"MF Marmor","year":"2016","unstructured":"Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF (2016) American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 123:1386\u20131394","journal-title":"Ophthalmology"},{"key":"3782_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ophtha.2014.07.056","volume":"122","author":"C Cukras","year":"2015","unstructured":"Cukras C, Huynh N, Vitale S, Wong WT, Ferris FL, Sieving PA (2015) Subjective and objective screening tests for hydroxychloroquine toxicity. Ophthalmology 122:356\u2013366","journal-title":"Ophthalmology"},{"key":"3782_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ajo.2012.09.025","volume":"155","author":"DJ Browning","year":"2013","unstructured":"Browning DJ (2013) Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice. Am J Ophthalmol 155:418\u2013428","journal-title":"Am J Ophthalmol"},{"key":"3782_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1167\/iovs.14-15138","volume":"56","author":"MG Lee","year":"2014","unstructured":"Lee MG, Kim SJ, Ham DI, Kang SW, Kee C, Lee J et al (2014) Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy. Invest Ophthalmol Vis Sci 56:396\u2013402","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3782_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.12.021","author":"RA Braslow","year":"2017","unstructured":"Braslow RA, Shiloach M, Macsai MS (2017) Adherence to hydroxychloroquine dosing guidelines by rheumatologists: an electronic medical record-based study in an integrated health care system. Ophthalmology. doi:\n                    10.1016\/j.ophtha.2016.12.021\n                    \n                   \n                           [Epub ahead of print]","journal-title":"Ophthalmology"},{"key":"3782_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","volume":"27","author":"SE Tett","year":"1989","unstructured":"Tett SE, Cutler DJ, Day RO, Brown KF (1989) Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol 27:771\u2013779","journal-title":"Br J Clin Pharmacol"},{"key":"3782_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613\u2013619","journal-title":"J Clin Epidemiol"},{"key":"3782_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"3782_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/intqhc\/mzn054","volume":"21","author":"H Sherman","year":"2009","unstructured":"Sherman H, Castro G, Fletcher M, Hatlie M, Hibbert P, Jakob R et al (2009) Towards an International Classification for Patient Safety: the conceptual framework. Int J Qual Health Care 21:2\u20138","journal-title":"Int J Qual Health Care"},{"key":"3782_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2016.03.044","volume":"166","author":"DJ Browning","year":"2016","unstructured":"Browning DJ (2016) The prevalence of hydroxychloroquine retinopathy and toxic dosing, and the role of the ophthalmologist in reducing both. Am J Ophthalmol 166:9\u201311","journal-title":"Am J Ophthalmol"},{"key":"3782_CR15","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA et al (1999) Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282:1458\u20131465","journal-title":"JAMA"},{"key":"3782_CR16","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.3747\/co.22.2235","volume":"22","author":"SF Hall","year":"2015","unstructured":"Hall SF, Irish JC, Gregg RW, Groome PA, Rohland S (2015) Adherence to and uptake of clinical practice guidelines: lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer. Curr Oncol 22:e61\u2013e68","journal-title":"Curr Oncol"},{"key":"3782_CR17","unstructured":"Schwartzman S (2016) My take on new ocular screening guidelines for plaquenil. RheumNow. \n                    http:\/\/rheumnow.com\/blog\/my-take-new-ocular-screening-guidelines-plaquenil#.WA1IG9L24n4.email\n                    \n                  . Accessed 25 Nov 2016"},{"key":"3782_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJM199101173240303","volume":"324","author":"The Canadian Hydroxychloroquine Study Group","year":"1991","unstructured":"The Canadian Hydroxychloroquine Study Group (1991) A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324:150\u2013154","journal-title":"N Engl J Med"},{"key":"3782_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1191\/096120398678919778","volume":"7","author":"E Tsakonas","year":"1998","unstructured":"Tsakonas E, Joseph L, Esdaile JM, Choquette D, Senecal JL, Cividino A et al (1998) A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. Lupus 7:80\u201385","journal-title":"Lupus"},{"key":"3782_CR20","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/art.39194","volume":"67","author":"M Jallouli","year":"2015","unstructured":"Jallouli M, Galicier L, Zahr N, Aumaotre O, Frances C, Le Guern V et al (2015) Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus. Arthritis Rheumatol 67:2176\u20132184","journal-title":"Arthritis Rheumatol"},{"key":"3782_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22962","author":"JY Lee","year":"2016","unstructured":"Lee JY, Lee J, Kwok SK, Ju JH, Park KS, Park SH (2016) Factors related to blood hydroxychloroquine concentration in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken). doi:\n                    10.1002\/acr.22962\n                    \n                   \n                           [Epub ahead of print]","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3782_CR22","unstructured":"Institute of Medicine (US) Committee on standards for developing trustworthy clinical practice guidelines (2011) In: Graham R, Mancher M, Miller Wolman D et al (eds) Chapter 6: promoting adoption of clinical practice guidelines. Clinical practice guidelines we can trust. National Academies Press, Washington. \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK209543\/"}],"updated-by":[{"DOI":"10.1007\/s00296-017-3918-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T00:00:00Z","timestamp":1513900800000}}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3782-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3782-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3782-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:55:53Z","timestamp":1589630153000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3782-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["3782"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3782-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00296-017-3918-8","asserted-by":"object"}]},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]},"assertion":[{"value":"7 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2017","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The given and family name of a co-author R. Adams Dudley was swapped in the published article. The correct given name is R. Adams and the family name is Dudley.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This work is supported by AHRQ R01 HS024412 (JY) and NIAMS K23 AR063770 (GS). Dr. Gianfrancesco has received funding from the Rheumatology Research Foundation. Dr. Yazdany is supported by the Robert L. Kroc Endowed Chair in Rheumatic and Connective Tissue Disorders. Drs. Yazdany and Schmajuk are also supported by the Russell\/Engleman Medical Research Center for Arthritis. Dr. Sirota is funded in part by the March of Dimes Prematurity Research Center.\u00a0Dr. Jafri is supported by an NIH T32 grant 5T32AR007304-38. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality, National Institute of Arthritis and Musculoskeletal and Skin Diseases, or National Institutes of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors report no conflicts of interest regarding this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}